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Abstract 
Arsenic exposure has been implicated by several epidemiological studies as an important metalloid that is currently 
poisoning millions of people globally. In order to investigate the time – course of arsenic exposure on hepatic and 
renal toxicity, male albino rats (n=45) were exposed to arsenic (100 ppm, 150 ppm and 200 ppm) for 4, 8 and 12 
weeks as sodium arsenate in their drinking water. Control animals (n=15) received distilled water for the same 
period after which blood and vital organs were removed from the animals and analyzed for alanine amino 
transaminase (ALT), aspartate amino transaminase (AST) gamma amino transaminase (γGT), alkaline phosphatase 
(ALP), creatinine and urea spectrophotometrically. Histological changes in hepatocytes was also examined. Before 
the commencement of arsenic exposure, five animals were sacrificed to obtain baseline data. Significant elevation 
in plasma ALT, AST, γGT and alkaline phosphatase activities characterized the effect of the arsenical at all doses 
and time interval relative to the controls. Plasma levels of creatinine and urea were also elevated at all-time 
intervals in the arsenic group. In most of the cases observed, the elevated level of these biochemical marker in 
circulation are time – and dose – dose dependent. Hepatic histopathology reveals degeneration of cytoplasmic 
contents, evidence of necrosis, collapse of central vein, cytoplasmic inclusion and enlarged hepatic sinusoids in 
arsenic – exposed groups. These findings suggest that different dose regimens of sodium arsenate at different time 
interval caused degenerative changes in hepatic and renal tissues in rats in dose – and time – dependent fashion. 
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1. Introduction 
Increasing human activities have led to the contamination of air, water, soil and food especially with the toxic, 
non-essential elements such as arsenic (As), mercury (Hg), cadmium (Cd) and lead (Pb) (Clarkson, 1995). Among 
these metals, arsenic, a ubiquitous metalloid, exhibits a complex metabolism and is possibly the most abundant 
pollutant (Hu, 2000; Pradosh & Anupama, 2000). In fact it is ranked first in a list of 20 hazardous substances by 
the Agency for Toxic Substances and Diseases Registry and United States Environmental Protection Agency 
(Goering, 1999).Arsenic, either as trivalent arsenite (AsIII) or pentavalent arsenate (AsV), is a naturally occurring 
common environmental toxicant that is widely distributed in the biosphere (Chowdhury et al., 2000; Haider & 
Najar, 2008). It is an epidemiologically important metalloids that is currently poisoning tens of millions of people 
worldwide (Hughes et al., 2011; Smeester et al., 2011). 
Arsenate is released from several anthropogenic sources such as mining wastes, mineral debris, glass manufacture, 
computer chips, wood preservatives, insecticides, and some agrochemicals (Rordriguezet et al., 2003), making it 
a global underground water contaminant (Guillamet et al., 2004; Odunola et al., 2008; Gbadegesin et al., 2009). 
In humans and some experimental animals, the inorganic form of arsenic has been established to be a potential 
carcinogen. The inorganic arsenic is methylated to monomethylarsonic acid (MMA) and finally to dimethylarsenic 
acid (DMA) and this metabolism is followed by urinal excretion. This arsenic biotransformation has been 
previously proven to lead to DNA hypomethylation arising from continuous depletion of methyl group resulting 
into aberration in gene expression, which in turn causes abnormality in cell proliferation that eventually results in 
carcinogenesis (Pradosh & Anupama, 2002). 
Previous studies have reported various arsenic-induced catastrophes (Hughes & Najar, 2011; Mazumber & 
Dasgupta, 2011), which include, but not limited to hypertension, diabetes mellitus, atherosclerosis, impaired 
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microcirculation, peripheral artery disorder coronary heart disease (CHD), stroke and various forms of cancer 
(Wang et al., 2006; States et al., 2009; Hughes et al., 2011; Mazumder & Dasgupta, 2011). All these arsenic – 
induced toxicity depend on many factors such as valence state, form (either organic or inorganic), particle size, 
solubility, rates of absorption and elimination (ATSDR, 2007). Epidemiologic evidences have demonstrated that 
ingestion of arsenic through drinking water might be responsible for the observed carcinogenic and non – 
cancinogenic effects of arsenic (States et al., 2009; Mazumder & Dasgupta, 2011; Roman et al., 2011). In acute 
lethality studies, trivalent arsenic (arsenite) was considered to be more toxic than pentavalent (arsenate) form 
(Albernathy et al., 1999; Ng, 2005). In terms of forms, inorganic arsenic was regarded as more toxic than organic 
species. However, animal studies have shown that methyl arsenicals – monomethylarsonic acid (MMA) and 
dimethylarsinic acid (DMA) could produce adverse health effects similar to those produced by inorganic arsenic, 
especially with respect to chronic exposure (ATSDR, 2007; Albernathy et al., 1999). 
Despite volumes of scientific findings about the toxic effects of arsenic, the time – course and possible mechanisms 
involved in arsenic – induced toxicity following acute and chronic arsenic exposure, as well as the threshold for 
biologic effects and disease risks remain enigmatic(Hughes et al., 2011).The present study however focused on 
the time – course of arsenic-induced hepatotoxicity and nephrotoxicity. 
 
2. Materials and Methods 
2.1 Chemicals 
All chemicals used in this study were of the purest grade available and were obtained from the British Drug House 
(BDH) Chemicals Limited, Poole, England and Sigma-Aldrich, Missouri, U. S. A. 
2.2 Animals and treatment 
Sixty five (65) male albino rats weighing between 120 – 140 g were purchased from the animal house, Department 
of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria. The animals were 
experimentally naïve, normal, and with no visible sign of diseases or injury. They were checked fully for rodent’s 
infectious diseases visually. The animals were caged in the animal house and allowed to acclimatize for 14 days 
before the commencement of arsenic exposure. They were allowed free access to standard rat pellet diet purchased 
from Vita Feeds Nigeria Limited and drinking water ad libitum. Animals were maintained at temperature of 
22±2°C and regular light-dark cycle (06:00-18:00h) throughout the study. 
Five (5) animals served as baseline and were sacrificed at the commencement of the study to obtain the baseline 
data. The remaining sixty (60) animals were randomly divided into twelve (12) groups of five (5) animals each. 
Nine (9) groups were exposed to 100 ppm, 150 ppm and 200 ppm inorganic arsenic as disodium arsenate 
(Na2HAsO4) in their drinking water each for four (4), eight (8) and twelve (12) weeks. The remaining three (3) 
groups served as control rats for each of the time intervals and received distilled water over the same period of 
time. 
At the end of arsenic exposure blood was collected from the animals into heparinised tubes by cardiac puncture 
under light ether anesthesia after an overnight fast. The blood samples were centrifuged at 5000 rpm for 10 min to 
obtain plasma and then stored at −20 ◦C until analysed. Liver was excised rinsed with normal saline and then 
divided into two portions. One portion was homogenized with phosphate buffer and the homogenate was kept at -
20°C until used. The second portion was kept in 10% formalin for histological analysis.  
2.3 Biochemical Assay 
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities were assayed in the plasma by 
using the Labkit® reagent kits according to the method of Reitman and Frankel (Reitman and Frankel, 
1957).Plasma γGT was also assayed using Labkit® reagent kits following the standard method of Szasz (Szasz, 
1969). ALP activity was assayed by the optimized standard method as recommended by Deutsche Gesellschaft fur 
Klinische Chemie (1972). Creatinine concentration was determined as described by Bartel et al. (Bartel et al., 
1972). Urea concentration was also determined by Urease-Berthelot method. 
2.3 Histopathology 
Harvested livers were rinsed in phosphate buffered saline, blotted dry on filter paper and weighed. Sections of the 
liver were fixed in 10% p-formaldehyde processed and embedded in paraffin. The formalin fixed, paraffin 
embedded tissue was further sectioned and layered onto glass slide which was stained with haematoxylin-eosin 
dye and finally examined under light microscope as previously described by Hochegger et al., (2005). 
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2.4 Statistical evaluation 
Results were expressed as mean ± SEM. One-way analysis of variance (ANOVA) followed by Tukey’s test was 
used to analyze the results with p < 0.05 considered significant.    
 
3. Results 
Table 1: Body, liver weight and relative weight change in rat exposed to inorganic arsenic for 4 weeks. 
 Initial body 
weight (g)  
Final Body 
Weight (g) 
% Weight 
change 
Liver weight (g) Relative liver 
weight 
Control 146.8±7.53 181±1.36a 23.30 5.6±1.01a 3.09±0.53a 
100 ppm 149.9±6.92 124±3.73b 17.00 5.93±1.38a 4.78±0.81b 
150 ppm 150±4.89 113.60±4.49c 24.27 8.53±0.64b 7.51±1.10c 
200 ppm 148.4±9.57 112.2±7.78d 24.39 7.7±0.99a 6.86±0.37d 
 
Table 2: Body, liver weight and relative weight change in rat exposed to inorganic arsenic for 8 weeks. 
 Initial body 
weight (g)  
Final Body 
Weight (g) 
% Weight 
change 
Liver weight (g) Relative liver 
weight 
Control 148.8±7.58 193.1±1.05a 29.77 5.91±1.21a 3.06±0.76a 
100 ppm 147.9±2.56 134.2±1.46b 9.26 6.09±1.11a 4.54±0.41b 
150 ppm 137±8.06 121±4.31c 11.68 6.91±0.88a 5.71±0.72c 
200 ppm 145.2±7.25 119±3.53d 18.04 6.61±0.53a 5.55±0.43d 
 
Table 3: Body, liver weight and relative weight change in rat exposed to inorganic arsenic for 12 weeks. 
 Initial body 
weight (g)  
Final Body 
Weight (g) 
% Weight 
change 
Liver weight (g) Relative liver 
weight 
Control 135.50±8.06 178.80±1.05a 31.96 6.55±1.49a 3.66±0.80a 
100 ppm 148.00±8.18 108.70±4.07b 25.55 7.14±1.08a 6.57±0.71b 
150 ppm 146.00±3.14 101.4±6.48c 30.55 8.52±0.78b 8.40±0.32c 
200 ppm 147.00±7.58 97.00±3.79d 34.01 8.20±0.91c 8.45±0.91d 
 
Tables 1, 2 and 3 summarizes the initial, terminal body weights, percentage weight change, liver weight and 
relative liver weight of the animals exposed to 100, 150 and 200 ppm inorganic arsenical for 4, 8 and 12 weeks 
respectively. Body weight of the animals in the control groups increased progressively by 23.30, 29.77 and 31. 96% 
respectively for 4, 8 and 12 weeks. Arsenic exposure led to a continuous reduction in body weight that is significant 
at all time interval and doses. As illustrated, in each time interval, the reduction in body weight increased with 
increasing doses of the arsenical. The most dramatic reduction in body weight of the magnitude 25.55, 30.55 and 
34.01% was elicited by 100, 150 and 300 ppm arsenic respectively after twelve weeks of exposure. 
Correspondingly, when compared with the control group, there was a significant increase in relative liver weight 
of the animals exposed to the arsenical. This observed increase in relative liver weight was dose – dependent at 
both 8 and 12 weeks of exposure.  
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Fig. 1: Plasma ALT level in rats exposed to different doses of inorganic arsenic. 
As shown in fig. 1, exposure of animals to low (100 ppm), intermediate (150 ppm) and high (200 ppm) doses of 
inorganic arsenate led to a time and dose dependent increase (p<0.05) in plasma level of AST. At 4 weeks. The 
three doses of 100, 150 and 200 ppm arsenic produced 20%, 30% and 64% increase respectively. Following the 
extension of the duration of the same doses of arsenic to 8 weeks the magnitude on the increment became 70%, 
87% and 95% respectively. Meanwhile, at 12 weeks the three doses of the arsenic compound increased the level 
of ALT in circulation to nearly 100% 
 
Fig.2: Plasma AST level in rats exposed to different doses of inorganic arsenic. 
As presented in fig. 2, exposure of animals to 100, 150 and 200 ppm inorganic arsenic for 4, 8 and 12 weeks 
increased the level of AST in circulation at all doses and duration of exposure. As illustrated in the figure the 
effects of 150 and 200 ppm arsenic was time dependent. At weeks, the three doses of the arsenic elicited a hormetic 
response in plasma AST levels. On the other hand, when the duration of exposure was increased to 8 and 12 weeks, 
the response to arsenic exposure was dose dependent. The maximal response to arsenic exposure was observed at 
12 weeks. Exposure to 100 and 200 ppm arsenate produced about 2.5 – fold increase in plasma AST level, while 
200 ppm caused about 3 – fold increase. 
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Fig.3: Plasma γGT level in rats exposed to different doses of inorganic arsenic. 
As depicted in fig. 3, exposure to 100, 150 and 200 ppm sodium arsenate for 4, 8 and 12 weeks induced a significant 
dose – and time – dependent increase in the activity of γGT in circulation. For instance, the minimal (2 – fold 
increase in plasma activity) and maximal (4 – fold increase in plasma activity) effects were elicited by exposure 
to 100 ppm for 4 weeks and 200 ppm for 12 weeks respectively. 
 
 
Fig.4: Plasma ALP level in rats exposed to different doses of inorganic arsenic. 
Exposure of the animals to the arsenical increased the plasma level of ALP significantly (fig. 4). The observed 
effect was dose dependent at both 4 and 12 weeks of exposure. On the other hand, after 8 weeks of exposure, the 
lowest dose of 100 ppm sodium arsenate caused the maximal effect on the plasma level of ALP, while the lowest 
effect was induced by the highest dose of 200 ppm.   
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Fig.5: Plasma Creatinine Concentration in rats exposed to different doses of inorganic arsenic. 
As depicted in fig 5, exposure to the three doses of the arsenicals up – regulated plasma creatinine level 
significantly. This increment in plasma creatinine concentration was dose – and time – dependent. For instance, 
the magnitude of the effect of exposure to 100 ppm inorganic arsenic for 4 weeks was 14% increase in plasma 
creatinine concentration. When the dose and duration of exposure was increased to 200 ppm and 12 weeks 
respectively, the magnitude the effects was increased to 100%. 
 
Fig.6: Plasma Urea Concentration in rats exposed to different doses of inorganic arsenic. 
The mean plasma urea concentrations of the animals is illustrated in fig. 6. Treated of the animals with doses of 
inorganic arsenic for 4, 8 and 12 weeks caused a significant increase in the concentration of urea in the plasma. 
Interestingly, the lowest dose of 100 ppm caused the most significant up – regulation of the plasma urea content. 
For instance, the dose regimen caused about 2, 3 and 5 folds increase in plasma urea concentration at 4, 8 and 12 
weeks of exposure respectively. The increment caused by the different dose regimens was sustained in a time – 
dependent fashion. 
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Fig. 7: Histologic Examination. 
 
A: Baseline: showing normal cytoarchitectcture of the hepatocytes (yellow arrow) and reticular fibres (yellow 
arrow) in the wall of central vein and sinusoids. The cells are centrally located with some some kupfer cells seen 
(X40) 
 
B: Control (4 weeks): showing normal cytoarchitectcture of the hepatocytes and reticular fibres (black arrow) in 
the wall of central vein and sinusoids. The nucleus are centrally located with some element of binucleation (yellow 
arrow) as a sign of normal cell division (X40). 
 
C: 100ppm of inorganic arsenate (4weeks): Showing distorted cytoarchitectecture with necrotic cells (black 
arrow), degenerated reticular fibres of the central vein (yellow arrow) and enlarged sinusoids (red arrow) (X40). 
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D: 150ppm of inorganic arsenate (4 weeks): Showing cells with degenerated cytoplasmic content (black arrow), 
anucleolus (red arrow) and necrotic cells (yellow arrow) (X40). 
 
E: 200ppm of inorganic arsenate (4 weeks): Showing normal hepatic cytoarchitectecture with necrotic cells 
(black arrow), and few cytoplasmic inclusion (red arrow) (X40). 
 
F: Control (8 weeks): showing normal cytoarchitectcture of the hepatocytes and reticular fibres (black arrow) in 
the wall of central vein and sinusoids. The nucleus are centrally located with some element of binucleation (yellow 
arrow) as a sign of normal cell division (X40). 
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G: 100ppm of inorganic arsenate (8 weeks): Showing distorted cytoarchitectecture with necrotic cells (black 
arrow) and a collapsed central vein (red arrow) (X40). 
 
H: 150ppm of inorganic arsenate (8 weeks): Showing cells a normal central vein with distorted cytoarchitecture 
mainly caused by cytoplasmic inclusion (X40). 
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I: 200ppm of inorganic arsenate (8 weeks): Showing enlarged hepatic sinusoids, undifferentiated 
cytoarchitectecture and hydropic degeneration of the hepatocytes (red arrow) (X40). 
 
J: Control (12 weeks): showing normal cytoarchitectcture of the hepatocytes and reticular fibres (black arrow) in 
the wall of portal vein and sinusoids. The cells are centrally located with some demonstration of cytoplasmic 
eosinophilic (red arrow) (X40). 
 
K: 100ppm of inorganic arsenate – 12 weeks: Showing some aggregate of inflammatory cells at the central vein 
(red arrow) (X40). 
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L: 150ppm of inorganic arsenate (12 weeks): Demonstrating showing hepatocytes with high cytoplasmic 
inclusions (red arrow) and some aggregate of inflammatory cells at the central vein (yellow arrow). The central 
vein appears normal (white arrow). 
 
M: 200ppm of inorganic arsenate (12 weeks): Demonstrating kupfer cell hyperplasia (red arrow) (X40). 
 
4. Discussion  
The results from the present study demonstrated that exposure of rats to pentavalent inorganic arsenic through the 
drinking water could be associated with hepatic and renal toxicities. Compared with the control animals, the 
arsenical caused a general and significant decline in the average weight of the animals, increased relative liver 
weight, perturbed levels of ALT, AST, γGT, ALP, creatinine and urea in circulation. These perturbations was 
characterized by a significant elevation in their respective concentration in the plasma. 
Exposure of animals to inorganic arsenic through their drinking water resulted into substantial loss in body weight 
compared with the control animals which shows a progressive increase in body weight, as such the arsenical even 
at dose as low as 100 ppm and as early as 4 weeks of exposure appears to have a huge overall systemic effect on 
the animals. Corroboratively, steady increase in relative liver weight was also observed in the groups that were 
exposed to the arsenic compound. The increase in relative liver weight may be as a result of increased number of 
hepatocytes caused by arsenic – induced unregulated hepatocyte proliferation. This finding is in agreement with 
the previous research by Owumi et al. (2015). In their study, they recorded the highest number of cells/mm2in 
groups with highest mean relative liver weight  
Hepatocytes are the major target for chemically induced injuries and this may be due to the very vital role of liver 
in the metabolism and detoxification of toxic chemical agents. There are high activities of xenobiotic metabolizing 
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enzymes in the liver, especially the cytochrome P450 – dependent monooxygenase system. The oxidative 
biotransformation by this enzyme produces many reactive metabolites that can induce plethora of damage effects 
on the hepatocytes (Jing & Teschke, 2018).  Assessment of plasma level of liver transaminases, such as ALT, AST 
and µGT has been found to be greatly important in the clinical and environmental investigation of liver injury. The 
raised levels of these enzymes in circulation are sensitive traditional marker of hepatic injury. These enzymes are 
synthesized in the hepatocytes and function in the metabolism of amino acids (Owumi et al., 2015), and are 
therefore used in determining occurrence of hepatocellular diseases. Our findings in the present study reveal that 
exposure of animals to inorganic arsenic for 4, 8 and 12 weeks significantly elevated the levels of ALT, AST and 
µGT in circulation (Figs 1, 2 and 3) relative to controls. This is an indication of arsenic – induced compromise of 
the hepatocytes structural integrity. This finding suggests that inorganic arsenate exposure at low, intermediate and 
high doses for 4, 8 and 12 weeks can damage hepatocytes and cause leakages of hepatic transaminases into the 
blood. 
ALP is a non – specific phosphoric monoesterase and a dimeric metalloenzyme containing Zn2+ and Mg2+ ions 
coordinated to its active site (Shyuan et al., 2008). It is a ubiquitous intracellular enzyme that catalyzes the 
hydrolysis of organic phosphoesters but as noted by Newsome et al. (2018), it is produced mainly in the liver. 
High plasma ALP activity has been found in patients with liver cancer (Bhudhisawasdi, et al., 2004).The present 
study noted elevated activities of ALP in the plasma of arsenic – exposed groups compared with the control (Fig 
4). This study had earlier observed increased relative liver weight in the arsenic group which at this point could be 
correlated with the observed elevated ALP activity and suggest that the elevated plasma ALP activity was as a 
result of arsenic – induced unregulated hepatocytes proliferation; a major feature of cancerous cells. 
Creatine is a dietary non – essential amino acid that is phosphorylated in the hepatocytes, kidney and pancreas by 
creatine kinase. The phosphorylated creatine is then subsequently released into circulation and stored by organs 
such as the muscle and brain for growth, tissue repair, and energy dependent activities (Newman and price, 2001; 
Bhagavan, 2002; Watras, 2008). In muscle however, creatine dephosphorylation releases energy needed for muscle 
contraction. About 2% of muscle free creatine are irreversibly and spontaneously converted to creatinine which in 
turn is released into circulation and freely filtered and excreted by the kidneys (Curhan and Mitch, 2008). 
Creatinine therefore is a by – product of normal muscle function. Its level in the blood is therefore a reflection of 
kidney function, and its elevated level in circulation is an indication of inefficient filtration by the kidney. Urea is 
the principal nitrogenous waste product of protein metabolism and just like creatinine, it is eliminated from the 
body almost exclusively by the kidneys in the urine. Plasma urea concentration therefore is also a reflection of the 
balance between hepatic urea production and renal urea elimination. Meanwhile, the highest levels of circulatory 
urea occur in the context of decreased urinary elimination of urea due to advanced renal diseases and associated 
marked reduction in glomerular filtration rate (GFR). This study however noticed elevated levels in both creatinine 
and urea in the arsenic – treated rats relative to the control groups. The elevated plasma creatinine and urea in the 
rats suggests that arsenic may potentially cause renal impairment due to tubular damage or reduced glomerular 
filtration (Vasudevan & Sreekumari, 2005). This finding therefore suggests the nephrotoxic potential of inorganic 
arsenic. 
Histopathological assessment of the experimental rats exposed to various dose regimens of inorganic arsenic for 
the three time interval was also carried out. There were disruption of normal cytoarchitecture, degeneration of 
cytoplasmic contents, evidence of necrosis, collapse of central vein, cytoplasmic inclusion, enlarged hepatic 
sinusoids with undifferentiated cytoarchitecture with hydropic degeneration of the hepatocytes and aggregate of 
inflammatory cells noticed at the central vein and kupfer cell hyperplasia in the arsenic – treated rats. Contrarily, 
the hepatic tissues of the baseline and control rats showed a normal feature with hepatocytes having central nucleus 
and some element of binucleation, a sign of normal cell division. 
 
5. Conclusion 
Taken together, it can be concluded from the findings of the present study that the hepatotoxicity and 
nephrotoxicity potential of inorganic arsenate is time dependent. Furthermore, it should also be emphasized that 
even at a very low dose and very few weeks of exposure, the arsenical is capable of compromising the integrity 
and efficiency of these vital organs. 
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